High STAT5 levels mediate imatinib resistance and indicate disease progression in chronic myeloid leukemia
Wolfgang Warsch(Medical University of Vienna), Veronika Sexl(University of Veterinary Medicine Vienna)
Cited by 187
Related Papers
Loss of HIF-1α in natural killer cells inhibits tumour growth by stimulating non-productive angiogenesis
|Nature Communications|2017|176
A kinase-independent role for CDK8 in BCR-ABL1+ leukemia
|Nature Communications|2019|73
Antibodies Directed against Lewis-Y Antigen Inhibit Signaling of Lewis-Y Modified ErbB Receptors
|Cancer Research|2004|66
Loss of JAK1 Drives Innate Immune Deficiency
|Frontiers in Immunology|2019|54